BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24420637)

  • 1. The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.
    Yin J; Zhu JM; Shen XZ
    Int J Cancer; 2015 Jan; 136(2):249-57. PubMed ID: 24420637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy.
    Chen YJ; Wu H; Shen XZ
    Cancer Lett; 2016 Sep; 379(2):245-52. PubMed ID: 26193663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insight into the role of RING-finger E3 ligases in glioma.
    Cao Y; Zhou H; Chen X; Li Y; Hu J; Zhou G; Wang L
    Biochem Soc Trans; 2021 Feb; 49(1):519-529. PubMed ID: 33544148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting E3 ubiquitin ligases for cancer therapy.
    Sun Y
    Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.
    Lipkowitz S; Weissman AM
    Nat Rev Cancer; 2011 Aug; 11(9):629-43. PubMed ID: 21863050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma].
    Brauckhoff A; Ehemann V; Schirmacher P; Breuhahn K
    Verh Dtsch Ges Pathol; 2007; 91():269-77. PubMed ID: 18314624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma and the ubiquitin-proteasome system.
    Dawson SP
    Biochim Biophys Acta; 2008 Dec; 1782(12):775-84. PubMed ID: 18778769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Following Ariadne's thread: a new perspective on RBR ubiquitin ligases.
    Wenzel DM; Klevit RE
    BMC Biol; 2012 Mar; 10():24. PubMed ID: 22420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Zhou Q; Lui VW; Yeo W
    Future Oncol; 2011 Oct; 7(10):1149-67. PubMed ID: 21992728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mrz1, a Novel Mitochondrial Outer Membrane RING Finger Protein, is Degraded Through the Ubiquitin-Proteasome Pathway in Schizosaccharomyces pombe.
    Liu Z; Zhang P; Li M; A L; Yang G; Yu Y; Lu H; Shang J; Huang Y
    Curr Microbiol; 2022 Sep; 79(10):309. PubMed ID: 36088506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RING finger E(3) ubiquitin ligases: structure and drug discovery.
    Chasapis CT; Spyroulias GA
    Curr Pharm Des; 2009; 15(31):3716-31. PubMed ID: 19925422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 ubiquitin ligases in cancer and implications for therapies.
    Wang D; Ma L; Wang B; Liu J; Wei W
    Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
    Landré V; Rotblat B; Melino S; Bernassola F; Melino G
    Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of nondegradable forked ubiquitin conjugates by ring-finger ligases and its prevention by S5a.
    Kim HT; Goldberg AL
    Methods Mol Biol; 2012; 832():639-52. PubMed ID: 22350918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion and diversification of BTL ring-H2 ubiquitin ligases in angiosperms: putative Rabring7/BCA2 orthologs.
    Aguilar-Hernández V; Medina J; Aguilar-Henonin L; Guzmán P
    PLoS One; 2013; 8(8):e72729. PubMed ID: 23951330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.